ASX:DNK Danakali (DNK) Stock Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield3.58%Price TargetN/A Stock AnalysisStock Analysis Get Danakali alerts: Email Address Ad WealthPressThe only candlestick pattern worth a darnIt’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again…Follow this link here and enter your email address to sign up… About DanakaliDanakali Limited, together with its subsidiaries, engages in the exploration of minerals in Eritrea, East Africa. The company focuses on the development of the Colluli potash project located in the Danakil Depression region of Eritrea. The company was formerly known as South Boulder Mines Ltd. and changed its name to Danakali Limited in June 2015. Danakali Limited was incorporated in 2001 and is based in North Perth, Australia.Read More Ad WealthPressThe only candlestick pattern worth a darnIt’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again…Follow this link here and enter your email address to sign up… DNK Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive DNK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Danakali and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 7/7 Dividend6/27/2024Dividend Payable7/07/2024Today9/07/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorBasic Materials Industry Agricultural Inputs Sub-IndustryReal Estate Current SymbolASX:DNK CUSIPN/A CIKN/A Webwww.danakali.com.au Phone61-8-6266-8368FaxN/AEmployees5,205Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$1.52 million Net Margins152,476.14% Pretax MarginN/A Return on Equity1.17% Return on Assets-2.02% Debt Debt-to-Equity RatioN/A Current Ratio290.78 Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.53 per share Price / BookN/AMiscellaneous Outstanding Shares368,330,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.73 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Seamus Ian Cornelius B.Juris (Age 58)L.L.B., L.L.M., LLB, LLM, Executive Chairman Comp: $248.06kMr. Gregory Ian MacPhersonChief Financial OfficerDr. Roderick Joseph McEachern (Age 66)Chief Operating Officer Comp: $469.92kMs. Melissa Kate Chapman A.C.I.S.AGIA, B.Com., C.P.A., Joint Company SecretaryMs. Catherine Grant-Edwards B.Com.C.A., Joint-Company SecretaryKey Competitors(TRC.L)LON:TRC26338 (ARL.L)LON:ARLAdvanced Oxygen TechnologiesOTCMKTS:AOXYAeris EnvironmentalASX:AEIAllegheny & Western RailwayOTC:AWRYView All Competitors DNK Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Danakali own? Based on aggregate information from My MarketBeat watchlists, some other companies that Danakali investors own include Knowles (KN), Aurinia Pharmaceuticals (AUPH), Athenex (ATNX), Ascendis Pharma A/S (ASND), Ardelyx (ARDX), Arcturus Therapeutics (ARCT) and Aptose Biosciences (APTO). This page (ASX:DNK) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Danakali Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Danakali With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DNK Stock Alerts